DIDB® – The Drug Interaction Database, is now part of Certara Announcement DIDB® – The Drug Interaction Databaseがサターラの一員に加わる 2023年6月20日ニュージャージー州プリンストン - バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), today announced it has acquired…Certara2023年6月21日
Certara Appoints new Chief Marketing Officer, Sheila Rocchio Announcement Certara Appoints new Chief Marketing Officer, Sheila Rocchio プリンストン、ニュージャージー:2023年6月13日 バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in biosimulation, today…Certara2023年6月14日
What’s New for SEND 2023 On-Demand Webinar What’s New for SEND 2023 This webinar will focus on several changes to the CDISC SEND standard that became active…Certara2023年6月12日
Certara Launches Version 8.4 of Phoenix™ Biosimulation Software for Drug Development Announcement Certara Launches Version 8.4 of Phoenix™ Biosimulation Software for Drug Development Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.— June…Certara2023年6月12日
Certara enhances CODEX Clinical Outcome Analytics Platform with AI Announcement Certara enhances CODEX Clinical Outcome Analytics Platform with AI Trial design and execution now accelerated by deep learning and data fabric capabilities. PRINCETON, NJ…Certara2023年6月8日
Unlocking Efficiency and Quality: What is New in Phoenix™️ 8.4? オンデマンド・ウェビナー Unlocking Efficiency and Quality: What is New in Phoenix™️ 8.4? Join us for an exclusive webinar as Certara introduces the highly anticipated version 8.4 of…Certara2023年6月5日
QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation Publication QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation Typical Quantitative Systems Pharmacology (QSP) workflows involve discussion of biology, supported by graphical diagrams, followed…Certara2023年5月25日